Related Experiment Video
Updated: Oct 24, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
George Markousis-Mavrogenis1, Petros P Sfikakis2,3, Loukia Koutsogeorgopoulou3
1Onassis Cardiac Surgery Center, Athens, Greece.
Insights
Cardiovascular magnetic resonance (CMR) detects early cardiovascular disease (CVD) in autoimmune rheumatic diseases (ARDs), aiding personalized treatment. This imaging technique identifies inflammation and fibrosis, crucial for managing high-risk patients.
Area of Science:
- Cardiology
- Rheumatology
- Medical Imaging
Background:
- Autoimmune rheumatic diseases (ARDs) significantly increase cardiovascular disease (CVD) incidence and mortality.
- Early detection of CVD in ARD patients is critical for improving outcomes.
- Cardiovascular magnetic resonance (CMR) offers a non-invasive method for early CVD assessment in ARD.
Purpose of the Study:
- To review the diagnostic capabilities of CMR in identifying CVD in ARD patients.
- To highlight how CMR findings guide treatment decisions for ARD patients.
- To summarize the role of CMR in the personalized management of ARD.
Main Methods:
- Utilizing balanced steady-state free precession (bSSFP) for cardiac anatomy and function assessment.
- Employing T2-weighted imaging (T2-W) and T2 mapping for myocardial edema detection.
- Applying late gadolinium enhancement (LGE) and T1 mapping/extracellular volume fraction (ECV) for fibrosis quantification.
Main Results:
- CMR parameters effectively identify myocardial edema and fibrosis in ARD patients.
- These parameters are instrumental in making informed treatment decisions.
- Despite the absence of multicenter studies, CMR applications are widespread in ARD management.
Conclusions:
- Tissue characterization with CMR enables early and reliable identification of CVD in ARD patients.
- CMR contributes significantly to the personalized management strategies for ARD patients.
- CMR imaging is a valuable tool for risk stratification and therapeutic guidance in this population.
Background/Aims:
The high incidence of cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs) is the main driver towards increased mortality in this patient group. Cardiovascular magnetic resonance (CMR) can non-invasively and robustly detect CVD in ARD patients at an early stage of development. The review summarises the diagnostic information provided by CMR in ARD patients.
Summary:
CMR uses a strong magnetic field combined with radio-frequency pulses (pulse sequences) to generate images. Firstly, balanced steady-state free precession (bSSFP) can be used for evaluating cardiac anatomy, mass, wall motion, atrial/ventricular function. Secondly, T2-weighted imaging (T2-W) can be used for oedema detection, which appears as a high signal intensity area on STIR (short tau inversion recovery) images. T2 mapping is a newer T2-W technique that can provide more optimal identification of myocardial oedema. Lastly, late gadolinium enhanced (LGE) T1-W images, taken 15 min. after injection of contrast agent, allow the detection of myocardial replacement fibrosis, which appears as a bright area in a background of black myocardium. However, LGE has inherent disadvantages for the assessment of diffuse myocardial fibrosis. Therefore, T1 mapping and extracellular volume fraction (ECV) have been developed to quantify diffuse myocardial fibrosis.
Results:
Although multicentre studies are still missing, the CMR parameters have been extensively applied for the identification of oedema/fibrosis and treatment decision making in ARDs.
Conclusions:
Tissue characterisation with CMR allows early and robust identification of CVD in ARD patients and contributes to personalized management in the patients.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction

